1. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis;Baron, J.H.; Connell, A.M.; Lennard-Jones, J.E.; Avery-Jones, F.;Lancet,1962
2. Optimum dose of sulphasalazine for maintenance of remission in ulcerative colitis;Khan, A.K.A.; Howes, D.T.; Piris, J.; Truelove, S.C.,1980
3. Adverse reactions during sulphasalazine treatment and the relation with drug metabolism and acetylator phenotype;Das, K.M.; Eastwood, M.A.; McManus, J.P.A.; Sircus, W.;N EnglJ Med
4. Exacerbation of diarrhoea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis;Austin, C.A.; Cann, P.A.; Jones, T.H.; Holdsworth, C.D.;Lancet,1984
5. 5-Aminosalicylic acid in a slow release preparations bioavailability, plasma level and;Rasmussen, S.N.; Bondeson, S.; Hivdberg, E.F.